Page last updated: 2024-11-08

isoglutamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID164697
CHEBI ID21305
SCHEMBL ID93831
MeSH IDM0166401

Synonyms (33)

Synonym
unii-00vze9y4wf
00vze9y4wf ,
pentanoic acid, 4,5-diamino-5-oxo-
4,5-diamino-5-oxopentanoic acid
dl-isoglutamine
328-48-3
isoglutamine ,
617-63-0
(+-)-4,5-diamino-5-oxopentanoic acid
pentanoic acid, 4,5-diamino-5-oxo-, (+-)-
AKOS006307044
glutamic acid 1-amide
SCHEMBL93831
AEFLONBTGZFSGQ-UHFFFAOYSA-N
4,5-diamino-5-oxopentanoic acid #
isoglutamine, dl-
4-aminoglutaramic acid
(+/-)-4-aminoglutaramic acid
FT-0697921
mfcd00135661
h-d-isogln-oh;d-isoglutamine
h-glu-nh
h-d-glu-nh
h-isogln-oh;l-isoglutamine
FT-0745012
Q6085727
DTXSID80901304
CHEBI:21305
4,5-diamino-5-oxovaleric acid
alpha-glutamine
4-amino-4-carbamoylbutanoic acid
4-amino-4-carbamoylbutyric acid
SY257468
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
amino acid amideAn amide of an amino acid formed formally by conversion of the carboxy group to a carboxamido group.
glutamic acid derivativeAn amino acid derivative resulting from reaction of glutamic acid at the amino group or either of the carboxy groups, or from the replacement of any hydrogen by a heteroatom. The definition normally excludes peptides containing glutamic acid residues.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.83 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]